Notal Vision

Executive Summary

Notal Vision is a digital health company specializing in remote patient monitoring for retinal diseases, with a primary focus on Age-related Macular Degeneration (AMD). Founded in 2009 and headquartered in Menlo Park, California, the company develops patient-operated diagnostic devices and proprietary AI algorithms to enable continuous, at-home monitoring of disease progression. By shifting care from the clinic to the home, Notal Vision aims to provide ophthalmologists with timely, data-driven insights for personalized treatment decisions, thereby advancing precision medicine in ophthalmology. The company's technology addresses a significant unmet need in AMD management, where early detection of disease progression is critical to preventing vision loss. Notal Vision's platform has the potential to reduce the burden on healthcare systems while improving patient outcomes through proactive intervention. As a private company, Notal Vision has not disclosed its funding or valuation, but its presence in the digital health space positions it well for growth as remote monitoring becomes increasingly integrated into standard care.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation home monitoring device70% success
• Q2 2026Publication of pivotal study data demonstrating clinical utility of remote monitoring in AMD80% success
• Q3 2026Strategic partnership with a major pharmaceutical or diagnostic company for commercial distribution50% success